02-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 1153 17 887 88 1071 165 1004
ERLYTX 76 1 52 2 24 6 37
GI 165 4 209 16 195 29 177
GU 385 10 522 41 499 91 554
LEUK 160 1 52 14 170 29 177
LUNG 204 4 209 15 183 28 170
LYMPH 425 6 313 33 402 65 396
MELAN 8 1 52 1 12 1 6
MMYEL 114 3 157 13 158 18 110
MULT 51 0 0 2 24 2 12
OTHER 44 1 52 1 12 3 18
Total 2785 48 2505 226 2750 437 2661

02-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
CCD 208 3 157 18 219 38 231
ERLYTX 2 0 0 0 0 0 0
GI 1 0 0 0 0 1 6
GU 5 0 0 3 37 3 18
LEUK 609 8 417 51 621 106 645
LUNG 375 12 626 36 438 62 377
OTHER 15 0 0 2 24 6 37
PEOLC 67 0 0 0 0 1 6
PREV 229 7 365 18 219 28 170
SXQOL 662 14 730 50 609 106 645
Total 2173 44 2295 178 2167 351 2135

02-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 1153 17 887 88 1071 165 1004
CCD 208 3 157 18 219 38 231
ERLYTX 78 1 52 2 24 6 37
GI 166 4 209 16 195 30 183
GU 390 10 522 44 536 94 572
LEUK 769 9 470 65 791 135 822
LUNG 579 16 835 51 621 90 548
LYMPH 425 6 313 33 402 65 396
MELAN 8 1 52 1 12 1 6
MMYEL 114 3 157 13 158 18 110
MULT 51 0 0 2 24 2 12
OTHER 59 1 52 3 37 9 55
PEOLC 67 0 0 0 0 1 6
PREV 229 7 365 18 219 28 170
SXQOL 662 14 730 50 609 106 645
Total 4958 92 4801 404 4918 788 4797

02-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 699 10 522 45 548 82 499
ERLYTX 54 1 52 2 24 4 24
GI 125 2 104 12 146 24 146
GU 284 8 417 25 304 60 365
LEUK 100 1 52 7 85 15 91
LUNG 129 2 104 10 122 20 122
LYMPH 277 5 261 22 268 43 262
MELAN 8 1 52 1 12 1 6
MMYEL 63 2 104 6 73 8 49
MULT 20 0 0 1 12 1 6
OTHER 43 0 0 0 0 2 12
Total 1802 32 1668 131 1594 260 1582

02-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
CCD 155 1 52 14 170 28 170
ERLYTX 2 0 0 0 0 0 0
GI 1 0 0 0 0 1 6
GU 5 0 0 3 37 3 18
LEUK 248 3 157 17 207 37 225
LUNG 225 5 261 23 280 40 244
OTHER 15 0 0 2 24 6 37
PEOLC 54 0 0 0 0 1 6
PREV 222 0 0 11 134 21 128
SXQOL 483 9 470 32 390 78 475
Total 1410 18 940 102 1242 215 1309

02-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 890 14 730 65 791 124 755
CCD 172 1 52 10 122 26 158
ERLYTX 56 1 52 2 24 4 24
GI 140 3 157 14 170 30 183
GU 323 9 470 29 353 73 444
LEUK 351 4 209 24 292 54 329
LUNG 383 7 365 32 390 66 402
LYMPH 277 5 261 22 268 43 262
MELAN 8 1 52 1 12 1 6
MMYEL 63 2 104 6 73 8 49
MULT 43 3 157 5 61 10 61
OTHER 128 0 0 2 24 8 49
PEOLC 58 1 52 3 37 3 18
PREV 222 0 0 11 134 21 128
SXQOL 483 9 470 32 390 78 475
Total 3597 60 3131 258 3141 549 3343

02-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 987 15 783 84 1023 154 937
ERLYTX 71 1 52 2 24 6 37
GI 100 4 209 12 146 19 116
GU 274 6 313 28 341 64 390
LEUK 130 1 52 13 158 25 152
LUNG 180 4 209 14 170 26 158
LYMPH 349 6 313 30 365 52 317
MMYEL 101 3 157 13 158 18 110
MULT 51 0 0 2 24 2 12
Total 2243 40 2088 198 2409 366 2229

02-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
Member 1871 28 1461 130 1583 273 1662
AFFIL 126 0 0 2 24 6 37
CCOP/NCORP 1215 22 1148 101 1230 196 1193
Non-SWOG 1737 33 1722 162 1972 304 1851
Total 4949 83 4331 395 4809 779 4743

02-OCT-2026 6:11

STUDIES OPENED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
LEUK S2507 ALL/ALAL, KMT2A-trans, Blina +/- Revumenib 1 Y 22-SEP-26

02-OCT-2026 6:11

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
OTHER NRGGY026 Endomet, Stage I-IV, Pac/Car w/ HER HYL/PHE 1 E 29-SEP-26
OTHER NRGBN003 Mening, Grd II, Observation vs Irradiation 1 E 28-SEP-26
OTHER NRGBN003 Mening, Grd II, Observation vs Irradiation 2 E 28-SEP-26
SXQOL NRG-CC013 HN Squamous Cell, Rec Chemo, BMX 1 E 23-SEP-26

02-OCT-2026 6:11

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 13
LUNG LUNGMAP NSCLC, Adv, Master 1 12
LUNG LUNGMAP NSCLC, Adv, Master 2 9
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 9
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 8
PREV NRGCC005 Colon,Non-AdvancedAdenomas,Colonoscopy5v10yrs 1 7
SXQOL S2013 I-CHECKIT: ICI toxicity risk prediction study 1 7
SXQOL S2205 ICE COMPRESS: Reduction of CIPN from Taxanes 1 7
LYMPH S2308 FL, LTB, Mosunetuzumab vs Rituximab 1 5
LUNG S1800E Non-Match: Docetaxel + Ramu +/- Cemiplimab 1 4
GU A032201 Renal Cell, High-Risk, Pembro+Tiv 1 3
MULT S2101 Melan or HNSCC, Adv, Cabo + Nivo 1 3
CCD S2417CD Colrec Surv, Follow-up w/ CTAC site 1 3